These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 6145420)

  • 1. Quipazine and induction of adrenal enzymes.
    Ekker M; Missala K; Sourkes TL
    Biochem Pharmacol; 1984 May; 33(10):1687-9. PubMed ID: 6145420
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced head-twitch response to quipazine of rats previously treated with methiothepin: possible involvement of dopaminergic system.
    Dall'Olio R; Vaccheri A; Montanaro N
    Pharmacol Biochem Behav; 1985 Jul; 23(1):43-8. PubMed ID: 2994121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alpha-difluoromethylornithine on polyamine biosynthesis and tyrosine hydroxylase induction in the adrenal gland of the rat subjected to stress or apomorphine.
    Ekker M; Sourkes TL
    Biochem Pharmacol; 1985 Apr; 34(8):1315-20. PubMed ID: 2859859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
    Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
    J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiserotonergic effect of antidepressives in quipazine-induced headshake behavior in the rat].
    Fischer W; Müller M
    Pharmazie; 1984 Nov; 39(11):776-7. PubMed ID: 6531385
    [No Abstract]   [Full Text] [Related]  

  • 6. The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced locomotor activity.
    Feigenbaum JJ; Yanai J; Klawans HL
    J Neural Transm; 1982; 54(3-4):145-51. PubMed ID: 7130970
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
    Lipham LB; Booth NH; Jernigan AD; Robbins JD; Hatch RC
    Am J Vet Res; 1986 May; 47(5):1089-91. PubMed ID: 3717731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative anorexigenic activity and other pharmacological properties of quipazine and its N-acyl derivatives].
    Trubitsyna TK; Asnina VV; Mashkovskiĭ MD
    Farmakol Toksikol; 1986; 49(1):44-9. PubMed ID: 3948987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in tyrosine hydroxylase and dopa decarboxylase induced by pharmacological agents.
    Dairman W; Christenson JG; Udenfriend S
    Pharmacol Rev; 1972 Jun; 24(2):269-89. PubMed ID: 4404613
    [No Abstract]   [Full Text] [Related]  

  • 10. 2-(2-Aminoethyl)-quinoline (D-1997): a novel agonist at 5-hydroxytryptamine1-like receptors in the canine basilar artery.
    Terrón JA; López-Muñoz FJ; Hong E; Villalón CM
    Arch Int Pharmacodyn Ther; 1994; 327(1):56-68. PubMed ID: 7944828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental pattern of ornithine decarboxylase activity, S-adenosylmethionine decarboxylase, and polyamines of rat adrenal glands.
    Ekker M; Sourkes TL
    Biol Neonate; 1987; 51(5):260-7. PubMed ID: 3593807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of 5-hydroxytryptamine (5-HT) receptors by quipazine [proceedings].
    Lansdown MR; Nash HL; Preston PR; Wallis DI
    Br J Pharmacol; 1979 May; 66(1):80P-81P. PubMed ID: 454965
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of quipazine on blood pressure in pithed rats.
    Shin YK; Svinareff P; Schmitt-Jubeau H; Schmitt H
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of serotonin2 (5-HT2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats.
    Alper RH; Snider JM
    J Pharmacol Exp Ther; 1987 Dec; 243(3):829-33. PubMed ID: 3320345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
    Friedman RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response of suprachiasmatic neurons of the rat hypothalamus to photic and serotonergic stimulation.
    Miller JD; Fuller CA
    Brain Res; 1990 May; 515(1-2):155-62. PubMed ID: 2357553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of cyclic AMP-dependent protein kinase(s) in the induction of ornithine decarboxylase in the regenerating rat liver and in the adrenal gland after unilateral adrenalectomy.
    Byus CV; Hedge GA; Russell DH
    Biochim Biophys Acta; 1977 Jun; 498(1):39-45. PubMed ID: 195633
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced amounts of S-adenosylmethionine decarboxylase in the adrenal glands of rats following administration of piribedil or 2-deoxyglucose.
    Ekker M; Sourkes TL; Gabor R
    Biochem Pharmacol; 1988 Oct; 37(19):3613-8. PubMed ID: 3178874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive comparison of quipazine and morphine.
    Minnema DJ; DeWitt L; Rosecrans JA
    Commun Psychopharmacol; 1980; 4(2):115-20. PubMed ID: 7428332
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of quipazine and fluoxetine on analgesic-induced catalepsy and antinociception in the rat.
    Malec D; Langwinski R
    J Pharm Pharmacol; 1980 Jan; 32(1):71-3. PubMed ID: 6102137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.